Tuesday, September 21, 2021

Health

Fewer than 3.5 % of Africans vaccinated against COVID – Africa CDC

GENEVA (Reuters) - Less than 3.5% of Africans are vaccinated against COVID-19, far short of its official target of 60%, John Nkengasong, director of Africa's Centers for Disease Control, said on...

UK plans COVID boosters for over 50s to cope with “bumpy” winter

By Alistair Smout LONDON (Reuters) -Britain will begin a broad-based COVID-19 vaccine booster programme for older and more vulnerable people soon as...

Factbox – Countries weigh need for booster COVID-19 shots

By Reuters Staff (Reuters) - COVID-19 vaccine booster shots will be made widely available to Americans this month,...

Exclusive – Indonesia aims to reopen to foreigners in November – minister

By Kate Lamb and Tom Allard JAKARTA (Reuters) - Indonesia plans to start opening its borders to foreigners...

Exclusive: WHO-backed vaccine hub for Africa to copy Moderna COVID-19 shot

By Wendell Roelf CAPE TOWN (Reuters) - Efforts to develop an African base for COVID-19 vaccine production will...

Malaysia’s germ-busting clown finds new role in pandemic

By Ebrahim Harris TAIPING, Malaysia (Reuters) - When the coronavirus pandemic struck Malaysia, Shaharul Hisam Baharudin, like many...

UK would not have approved Valneva COVID vaccine, health secretary says

LONDON (Reuters) - Britain cancelled its contract for about 100 million doses of a COVID-19 vaccine being developed by France's Valneva in part because it was clear it would not be...

What you need to know about the coronavirus right now

(Reuters) - Here's what you need to know about the coronavirus right now: UK says vaccines have saved...

UK likely to require health workers to be vaccinated against COVID

LONDON (Reuters) -Britain is highly likely to require front-line health and social care workers in England to be vaccinated against COVID-19 as part of its plan to contain the virus through the winter. ...

Emergent to make Providence Therapeutics potential COVID-19 vaccine

(Reuters) -Emergent BioSolutions Inc signed a five-year agreement with Canadian biotechnology company Providence Therapeutics to develop and manufacture its COVID-19 vaccine candidate for about $90 million. ...

Latest news